Nephron sparing surgery in von Hippel-Lindau associated renal cell carcinoma; Clinicopathological long-term follow-up

Familial Cancer

Volumn 11, Issue 3, 2012, Pages 387-394

  Jilg, C A ^a   Neumann, Hartmut P H ^b   Glasker S ^a   Schafer O ^a   Leiber, C ^a   Ardelt, P U ^a   Schwardt, M ^a   Schultze Seemann, W ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Nephron sparing surgery; Renal cell carcinoma; Von Hippel Lindau disease

Indexed keywords

ABLATION THERAPY; ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; DIALYSIS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HUMAN; INTRAOPERATIVE PERIOD; KIDNEY CARCINOMA; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; METASTASIS; NEPHRECTOMY; NEPHRON SPARING SURGERY; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RISK FACTOR; TUMOR VOLUME; VON HIPPEL LINDAU DISEASE;

ADOLESCENT; ADULT; AGED; CARCINOMA, RENAL CELL; DIALYSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; NEPHRECTOMY; NEPHRONS; POSTOPERATIVE CARE; SURVIVAL RATE; TIME FACTORS; TREATMENT OUTCOME; VON HIPPEL-LINDAU DISEASE; YOUNG ADULT;

EID: 84870419956     PISSN: 13899600     EISSN: 15737292     Source Type: Journal    
DOI: 10.1007/s10689-012-9525-7     Document Type: Article

References (36)

1. Maher ER, Yates JR, Harries R, Benjamin C, Harris R, Moore AT, Ferguson-SmithMA(1990) Clinical features and natural history of von Hippel-Lindau disease. Q J Med 77(283):1151-1163
2. Goldfarb DA, Neumann HP, Penn I, Novick AC (1997) Results of renal transplantation in patients with renal cell carcinoma and von Hippel-Lindau disease. Transplantation 64(12):1726-1729
3. Gnarra JR, Glenn GM, Latif F, Anglard P, Lerman MI, Zbar B, Linehan WM (1993) Molecular genetic studies of sporadic and familial renal cell carcinoma. Urol Clin North Am 20(2):207-216
4. Latif F, Tory K, Gnarra J, Yao M, Duh FM, Orcutt ML, Stackhouse T, Kuzmin I, Modi W, Geil L et al (1993) Identification of the von Hippel-Lindau disease tumor suppressor gene. Science 260(5112):1317-1320
5. Neumann HP, Wiestler OD (1991) Clustering of features of von Hippel-Lindau syndrome: evidence for a complex genetic locus. Lancet 337(8749):1052-1054
6. Whaley JM, Naglich J, Gelbert L, Hsia YE, Lamiell JM, Green JS, Collins D, Neumann HP, Laidlaw J, Li FP et al (1994) Germline mutations in the von Hippel-Lindau tumor-suppressor gene are similar to somatic von Hippel-Lindau aberrations in sporadic renal cell carcinoma. Am J Hum Genet 55(6):1092-1102
7. Beroukhim R, Brunet JP, Di Napoli A, Mertz KD, Seeley A, Pires MM, Linhart D, Worrell RA, Moch H, Rubin MA et al (2009) Patterns of gene expression and copy-number alterations in von Hippel-Lindau disease-associated and sporadic clear cell carcinoma of the kidney. Cancer Res 69(11):4674-4681
8. Stenson PD, Ball EV, Mort M, Phillips AD, Shiel JA, Thomas NS, Abeysinghe S, Krawczak M, Cooper DN (2003) Human gene mutation database (HGMD): 2003 update. Hum Mutat 21(6): 577-581
9. Beroud C, Joly D, Gallou C, Staroz F, Orfanelli MT, Junien C (1998) Software and database for the analysis of mutations in the VHL gene. Nucleic Acids Res 26(1):256-258
10. Nordstrom-O'Brien M, van der Luijt RB, van Rooijen E, van den Ouweland AM, Majoor-Krakauer DF, Lolkema MP, van Brussel A, Voest EE, Giles RH (2010) Genetic analysis of von Hippel-Lindau disease. Hum Mutat 31(5):521-537
11. Neumann HP, Bender BU, Berger DP, Laubenberger J, Schultze-Seemann W, Wetterauer U, Ferstl FJ, Herbst EW, Schwarzkopf G, Hes FJ et al (1998) Prevalence, morphology and biology of renal cell carcinoma in von Hippel-Lindau disease compared to sporadic renal cell carcinoma. J Urol 160(4):1248-1254
12. Filling-Katz MR, Choyke PL, Oldfield E, Charnas L, Patronas NJ, Glenn GM, Gorin MB, Morgan JK, Linehan WM, Seizinger BR et al (1991) Central nervous system involvement in von Hippel-Lindau disease. Neurology 41(1):41-46
13. Neumann HP, Eggert HR, Scheremet R, Schumacher M, Mohadjer M, Wakhloo AK, Volk B, Hettmannsperger U, Riegler P, Schollmeyer P et al (1992) Central nervous system lesions in von Hippel-Lindau syndrome. J Neurol Neurosurg Psychiatr 55(10):898-901
14. Walther MM, Choyke PL, Glenn G, Lyne JC, Rayford W, Venzon D, Linehan WM (1999) Renal cancer in families with hereditary renal cancer: prospective analysis of a tumor size threshold for renal parenchymal sparing surgery. J Urol 161(5): 1475-1479
15. USRDS (2010) Annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD
16. Walther MM, Lubensky IA, Venzon D, Zbar B, Linehan WM (1995) Prevalence of microscopic lesions in grossly normal renal parenchyma from patients with von Hippel-Lindau disease, sporadic renal cell carcinoma and no renal disease: clinical implications. J Urol 154(6):2010-2014; discussion 2014-2015
17. Herring JC, Enquist EG, Chernoff A, Linehan WM, Choyke PL, Walther MM (2001) Parenchymal sparing surgery in patients with hereditary renal cell carcinoma: 10-year experience. J Urol 165(3):777-781
18. Joly D, Mejean A, Correas JM, Timsit MO, Verkarre V, Deveaux S, Landais P, Grunfeld JP, Richard S (2011) Progress in nephron sparing therapy for renal cell carcinoma and von Hippel-Lindau disease. J Urol 185(6):2056-2060
19. Roupret M, Hopirtean V, Mejean A, Thiounn N, Dufour B, Chretien Y, Chauveau D, Richard S (2003) Nephron sparing surgery for renal cell carcinoma and von Hippel-Lindau's disease: a single center experience. J Urol 170(5):1752-1755
20. Ploussard G, Droupy S, Ferlicot S, Ples R, Rocher L, Richard S, Benoit G (2007) Local recurrence after nephron-sparing surgery in von Hippel-Lindau disease. Urology 70(3):435-439
21. Duffey BG, Choyke PL, Glenn G, Grubb RL, Venzon D, Linehan WM, Walther MM (2004) The relationship between renal tumor size and metastases in patients with von Hippel-Lindau disease. J Urol 172(1):63-65
22. Matin SF, Ahrar K, Wood CG, Daniels M, Jonasch E (2008) Patterns of intervention for renal lesions in von Hippel-Lindau disease. BJU Int 102(8):940-945
23. Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2): 205-213
24. Becker F, Van Poppel H, Hakenberg OW, Stief C, Gill I, Guazzoni G, Montorsi F, Russo P, Stockle M (2009) Assessing the impact of ischaemia time during partial nephrectomy. Eur Urol 56(4):625-634
25. Ljungberg B, Cowan NC, Hanbury DC, Hora M, Kuczyk MA, Merseburger AS, Patard JJ, Mulders PF, Sinescu IC (2010) EAU guidelines on renal cell carcinoma: the 2010 update. Eur Urol 58(3):398-406
26. Johnson A, Sudarshan S, Liu J, Linehan WM, Pinto PA, Bratslavsky G (2008) Feasibility and outcomes of repeat partial nephrectomy. J Urol 180(1):89-93 (discussion 93)
27. Shuin T, Yamasaki I, Tamura K, Okuda H, Furihata M, Ashida S (2006) Von Hippel-Lindau disease: molecular pathological basis, clinical criteria, genetic testing, clinical features of tumors and treatment. Jpn J Clin Oncol 36(6):337-343
28. Rocco MV, Frankenfield DL, Hopson SD, McClellan WM (2006) Relationship between clinical performance measures and outcomes among patients receiving long-term hemodialysis. Ann Int Med 145(7):512-519
29. Gupta GN, Peterson J, Thakore KN, Pinto PA, Linehan WM, Bratslavsky G (2010) Oncological outcomes of partial nephrectomy for multifocal renal cell carcinoma greater than 4 cm. J Urol 184(1):59-63
30. Magera JS Jr, Frank I, Lohse CM, Leibovich BC, Cheville JC, Blute ML (2008) Analysis of repeat nephron sparing surgery as a treatment option in patients with a solid mass in a renal remnant. J Urol 179(3):853-856
31. Bratslavsky G, Liu JJ, Johnson AD, Sudarshan S, Choyke PL,Linehan WM, Pinto PA (2008) Salvage partial nephrectomy for hereditary renal cancer: feasibility and outcomes. J Urol 179(1):67-70
32. Choyke PL, Glenn GM, Walther MM, Zbar B, Weiss GH, Alexander RB, Hayes WS, Long JP, Thakore KN, Linehan WM (1992) The natural history of renal lesions in von Hippel-Lindau disease: a serial CT study in 28 patients. AJR Am J Roentgenol 159(6):1229-1234
33. Pahernik S, Ziegler S, Roos F, Melchior SW, Thuroff JW (2007) Small renal tumors: correlation of clinical and pathological features with tumor size. J Urol 178(2):414-417 (discussion 416-417)
34. Remzi M, Ozsoy M, Klingler HC, Susani M, Waldert M, Seitz C, Schmidbauer J, Marberger M (2006) Are small renal tumors harmless? Analysis of histopathological features according to tumors 4 cm or less in diameter. J Urol 176(3):896-899
35. Jilg CA, Neumann HP, Gläsker S, Schäfer O, Ardelt PU, Schwardt M, Schultze-Seemann W (2012) Growth Kinetics in Von Hippel-Lindau-associated renal cell carcinoma. Urol Int 88(1):71-78
36. Steinbach F, Novick AC, Zincke H, Miller DP, Williams RD, Lund G, Skinner DG, Esrig D, Richie JP, de Kernion JB et al (1995) Treatment of renal cell carcinoma in von Hippel-Lindau disease: a multicenter study. J Urol 153(6):1812-1816